Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Design Therapeutics Inc (NASDAQ: DSGN) closed the day trading at $4.24 up 4.43% from the previous closing price of $4.06. In other words, the price has increased by $4.43 from its previous closing price. On the day, 0.92 million shares were traded. DSGN stock price reached its highest trading level at $4.6036 during the session, while it also had its lowest trading level at $4.02.
Ratios:
For a better understanding of DSGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 41.42 and its Current Ratio is at 41.42. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 07, 2024, Upgraded its rating to Overweight and sets its target price to $12 from $6 previously.
On November 14, 2023, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $42 to $6.
Wedbush Downgraded its Outperform to Neutral on August 15, 2023, whereas the target price for the stock was revised from $19 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 09 ’24 when Logos SPV 1 LP bought 814,874 shares for $4.24 per share.
Schmid John P. bought 17,809 shares of DSGN for $66,606 on Mar 25 ’24. The Director now owns 26,965 shares after completing the transaction at $3.74 per share. On Mar 25 ’24, another insider, Berger Heather A., who serves as the Director of the company, bought 1,300 shares for $3.74 each. As a result, the insider paid 4,866 and bolstered with 1,300 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 240070912 and an Enterprise Value of -18241974.
Stock Price History:
Over the past 52 weeks, DSGN has reached a high of $7.83, while it has fallen to a 52-week low of $1.94. The 50-Day Moving Average of the stock is 5.62%, while the 200-Day Moving Average is calculated to be 32.88%.
Shares Statistics:
Over the past 3-months, DSGN traded about 177.14K shares per day on average, while over the past 10 days, DSGN traded about 275680 shares per day. A total of 56.47M shares are outstanding, with a floating share count of 33.25M. Insiders hold about 41.28% of the company’s shares, while institutions hold 42.41% stake in the company. Shares short for DSGN as of 1721001600 were 3047306 with a Short Ratio of 20.07, compared to 1718323200 on 2867329. Therefore, it implies a Short% of Shares Outstanding of 3047306 and a Short% of Float of 11.9799994.
